US panel replaced under Trump backs new shot for kids
The vote marked the first by the Advisory Committee on Immunization Practices (ACIP) since Kennedy dismissed all members of the influential group of independent experts and replaced them with his own nominees, a move that made this decision a test of the new panel's intentions.
Clesrovimab was recently approved by the Food and Drug Administration as a shot for newborns and young babies experiencing their first respiratory syncytial virus (RSV) season.
Marketed under the name Enflonsia by its manufacturer Merck, it was shown in clinical trials to be safe and effective at significantly reducing RSV infections and hospitalizations among infants.
The ACIP panel was asked to adjudicate the next step after approval -- namely, whether it should now be recommended for infants under eight months old entering their first RSV season who are not already protected by an RSV vaccine administered to their mother during pregnancy.
They voted 5-2 in favor.
The two dissenters were Retsef Levi, a professor of operations management at MIT who has questioned the safety of Covid-19 vaccines, and Vicky Pebsworth, a nurse and member of the anti-vaccine National Vaccine Information Center (NVIC).
"I don't feel this is ready to be administered to all healthy babies. I think we should take a more precautionary approach," said Levi, explaining his "no" vote.
Pebsworth did not offer comments, but the NVIC previously opposed the earlier-approved RSV antibody, nirsevimab.
Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 members of the ACIP earlier this month, accusing them of conflicts of interest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
France 24
4 hours ago
- France 24
US signals 'powerful shift' in vaccine policy as RFK Jr fires experts
An advisory panel for US Health Secretary Robert F. Kennedy Jr has voted to rescind recommendations for the flu vaccine, The New York Times reports. Kennedy recently fired 17 experts on the advisory panel, replacing them with eight anti-vaxxers. On Thursday the panel voted to walk back vaccine recommendations for the common flu. The reason? A common (and false) argument of anti-vaxxers: that thimerosol, an ingredient in the flu vaccine is linked to autism. The Times says the decision signals a "powerful shift" in the way federal officials approach vaccines. It also delivers the first blows to a scientific process that has provided effective and tested vaccines to Americans for decades. It's important to note, as the Australian academic website The Conversation explains, that the preservative thimerosol is mercury-based and used in some drug products because it prevents contamination by killing microbes. However, it is hardly ever used in flu vaccines today. The website explains that the argument that vaccines cause autism first surfaced in 1998 when a now-discredited report in the medical journal The Lancet was published, claiming that several children developed autism following the flu vaccine. The Financial Times reports that the Trump administration will also stop funding for GAVI, the global vaccine group that provide free shots for meningitis, malaria and other disease prevention to people in poor countries. Kennedy says the alliance has ignored science and failed to justify billions of dollars the US gives in funding. The US being the alliance's top donor, this decision will sharply dent GAVI's efforts to raise over $9 billion for vaccination campaigns dedicated to a half a billion children in the next five years. The Washington Post's editors, meanwhile, profile Susan Monarez, a respected scientist who is acting director of the Centers for Disease Control and Prevention and who could be on track to hold the position permanently. She had a confirmation hearing this week with US senators and impressed with her ability to avoid contradicting Kennedy's decision and avoid endorsing it at the same time. The Post's editors say that if confirmed, she could be a real impediment to those seeking to upend vaccine policies that have saved countless lives. French newspaper Libération looks at the famine in Gaza on its front page and asks the question: Is famine being used as a weapon of war by Israel in Gaza? The paper investigates the chaotic distribution of humanitarian aid in the Strip. Liberation explains that the system of aid is built around the Gaza Humanitarian Foundation (GHF), an American NGO and the only organisation allowed to distribute aid. Traditional NGOs are refusing to work with the GHF, telling Libération they believe it has militarised humanitarian aid and facilitated the chaos. Over 500 people have been killed since the GHF set up its aid distribution points. Libération also accuses the Israeli army of setting up aid mainly in the south of the enclave, cutting off aid to the rest of the population – a form of ethnic cleansing, it says. Finally, the controversial nuptials of Amazon founder Jeff Bezos are underway in Venice this weekend. His opulent three-day wedding celebration has drawn support from Venetian business owners who are happy to cater to the hordes of rappers, celebrities and tech billionaires descending on the Italian city. Nonetheless, it's sparked widespread protests from locals and activists fed up with the added strain it will put on a region that's already suffering from overtourism. Il Giorno, the Italian paper, looks at the controversial wedding of "Mister Amazon" and Lauren Sanchez. In many ways, The New York Times says, San Giorgio, where emperors once met with popes, is fit to host the patron of Protesters say it's not about the wedding but what it represents: the Americanisation of an inherently European city, and a tech billionaire who's cosied up to US President Donald Trump.
France 24
18 hours ago
- France 24
RFK Jr panel votes against ingredient targeted by anti-vaxxers
Thimerosal, a preservative that prevents bacterial and fungal contamination in multidose vials, has been extensively studied, with authorities including the World Health Organization finding no evidence of harm beyond minor injection-site reactions. Although the substance is now rarely used in US vaccines, the recommendations by the influential Advisory Committee on Immunization Practices alarmed experts, who say the move has effectively embedded talking points championed by the anti-vaccine movement into national policy. Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 ACIP members earlier this month, accusing them without evidence of conflicts of interest. Across three votes, his new panelists recommended that thimerosal be removed from influenza vaccines for children, pregnant women and finally all adults. Cody Meissner, a professor of pediatrics at Dartmouth University and the lone voice of dissent, said: "The risk from influenza is so much greater than the nonexistent risk as far as we know from thimerosal," adding that he was worried about the decision's global impact. Although 96 percent of US flu vaccines in the 2024-2025 season did not contain thimerosal, the preservative remains important in lower income countries because they are more likely to use lower cost multidose vials that must be punctured repeatedly, raising the risk of contamination. Thimerosal contains an artificial form of mercury called ethylmercury that is cleared from the body far more quickly than the form of the chemical found in nature. US manufacturers voluntarily removed it from most pediatric vaccines in 2001. 'Platform for anti-vaccine talking points' "The fact that it's being brought up again -- something that's already been adjudicated -- shows how the ACIP is becoming a platform for anti-vaccine talking points to come back to life long after most of us thought they'd been put to rest," Amesh Adalja, an infectious disease specialist at Johns Hopkins University, told AFP. Ahead of the vote, Lyn Redwood, a nurse and former leader of the anti-vaccine group Children's Health Defense, which Kennedy once chaired, was invited to present arguments against thimerosal. A previous version of her slideshow, which was posted online before the meeting, was removed without explanation after it was found to contain a fabricated citation. The Centers for Disease Control and Prevention had prepared a rebuttal to Redwood's presentation, but it was removed from the meeting website. Robert Malone, a new panel member known for spreading misinformation during the Covid-19 pandemic, including promoting the antiparastic drug ivermectin to treat the virus, said the CDC document had not been approved by the Office of the Secretary. "We now have a CDC ACIP that is voting based on vibes from an embarrassingly bad presentation from an external speaker," Jeremy Faust, an emergency physician and editor-in-chief of MedPage Today, told AFP. "Taking thimerosal out of the few vaccines it's in won't change anything other than give credence to discredited notion. That will undermine confidence in vaccines, not improve it." © 2025 AFP
France 24
a day ago
- France 24
US panel replaced under Trump backs new shot for kids
The vote marked the first by the Advisory Committee on Immunization Practices (ACIP) since Kennedy dismissed all members of the influential group of independent experts and replaced them with his own nominees, a move that made this decision a test of the new panel's intentions. Clesrovimab was recently approved by the Food and Drug Administration as a shot for newborns and young babies experiencing their first respiratory syncytial virus (RSV) season. Marketed under the name Enflonsia by its manufacturer Merck, it was shown in clinical trials to be safe and effective at significantly reducing RSV infections and hospitalizations among infants. The ACIP panel was asked to adjudicate the next step after approval -- namely, whether it should now be recommended for infants under eight months old entering their first RSV season who are not already protected by an RSV vaccine administered to their mother during pregnancy. They voted 5-2 in favor. The two dissenters were Retsef Levi, a professor of operations management at MIT who has questioned the safety of Covid-19 vaccines, and Vicky Pebsworth, a nurse and member of the anti-vaccine National Vaccine Information Center (NVIC). "I don't feel this is ready to be administered to all healthy babies. I think we should take a more precautionary approach," said Levi, explaining his "no" vote. Pebsworth did not offer comments, but the NVIC previously opposed the earlier-approved RSV antibody, nirsevimab. Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 members of the ACIP earlier this month, accusing them of conflicts of interest.
